List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.5.3.1. For curative treatment |
Others observations: For use in the management of severe malaria. To be used in combination with either amodiaquine, mefloquine or sulfadoxine + pyrimethamine. |
List | Section | Observation |
---|---|---|
PAHO Strategic Fund Medicine List | 2.7.2. Anti-malarial |
Others observations: Product may be co-packaged with 1 ampoule of 5% sodium bicarbonate solution and 1 ampoule of sodium chloride solution. |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.5.3.1. For curative treatment |
This medicine is only for children. Others observations: To be used in combination with either amodiaquine, mefloquine or sulfadoxine + pyrimethamine. For pre-referral treatment of severe malaria only; patients should be taken to an appropriate health facility for follow-up care. |
PAHO Strategic Fund Medicine List | 2.7.2. Anti-malarial | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.5.3.1. For curative treatment |
This medicine is only for children. Others observations: To be used in combination with either amodiaquine, mefloquine or sulfadoxine + pyrimethamine. For pre-referral treatment of severe malaria only; patients should be taken to an appropriate health facility for follow-up care. |
PAHO Strategic Fund Medicine List | 2.7.2. Anti-malarial | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.5.3.1. For curative treatment |
This medicine is only for children. Others observations: For pre-referral treatment of severe malaria only; patients should be taken to an appropriate health facility for follow-up care [c]. To be used in combination with either amodiaquine, mefloquine or sulfadoxine + pyrimethamine. |
List | Section | Observation |
---|---|---|
Peru | 6.5.3 Antimalarials | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 6.5.3.1. For curative treatment |
Others observations: To be used in combination with either amodiaquine, mefloquine or sulfadoxine + pyrimethamine. |
Bolivia | LINAME 2011 - 2013 | No observations |
Peru | 6.5.3 Antimalarials | No observations |
List | Section | Observation |
---|---|---|
Peru | 6.5.3 Antimalarials | No observations |
List | Section | Observation |
---|---|---|
Venezuela (incomplete) | List of Generic Medications - Venezuela | No observations |